To investigate the potential mechanism underlying the effect of salidroside on NASH, insulin signaling was assessed, first, based on mRNA levels of IRS1, PI3K, and PKB in the liver. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.